The Global Drugmakers Pfizer and BioNtech’s COVID Vaccine has showed 95 per cent efficacy. The two firms are now hoping to deliver the Vaccine before the Christmas. BioNTech CEO Ugur Sahin has said that “If all goes well I could imagine that we gain approval in the second half of December and start deliveries before Christmas, but really only if all goes positively.”
Pfizer and BioNtech’s Coronavirus Vaccine has given 95% efficacy in the last stage trial. Both the American pharmaceutical giant Pfizer and its German partner BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2.
Comments are closed, but trackbacks and pingbacks are open.